文献速递药物相互作用

药物相互作用监测研究:五种实证示例中自我对照设计的比较

Drug-Drug Interaction Surveillance Study: Comparing Self-Controlled Designs in Five Empirical Examples in Real-World Data.
PubMed 文献 · Clin Pharmacol Ther · 2020-12-17

该研究利用美国商业保险数据库(2006-2016),在五个药物相互作用-结局示例中比较了自身对照设计中的病例交叉(CCO)与自身对照病例系列(SCCS)。多数示例中两设计估计相似,SCCS统计效率更高;但结果随敏感性分析变化,尤其CCO暴露个体少时。通过对照组进行偏倚调整对结果影响大于设计选择,凸显对照组选择的重要性与挑战。

要点

  • 在多数药物相互作用示例中,CCO与SCCS设计得出相似估计,SCCS统计效率更优。
  • CCO分析在暴露个体较少时结果随敏感性分析变化较大。
  • 对照组偏倚调整对结果的影响大于设计选择,强调对照组选择的关键性。

核心结论

  • 在五个药物相互作用-结局示例中,CCO与SCCS设计多数得到相似估计,但对照组偏倚调整的影响大于设计选择。

研究设计与样本

  • 使用美国全国商业医疗保险数据库(2006-2016)开展自身对照设计比较研究,比较CCO与SCCS在五个DDI-结局示例中的表现。

主要发现

  • 多数示例中两设计估计相似,SCCS显示更好的统计效率。
  • 两设计结果在敏感性分析中均有变化,尤其CCO分析暴露个体较少时。
  • 在对照组中分析揭示 substantial 偏倚,且可能在DDI暴露与对照个体间存在差异。
  • 两设计均显示达比加群暴露者中胺碘酮或维拉帕米与出血无关联,但在对照组中显示强正关联。

临床怎么用

  • 在自我对照设计的DDI研究中,应重视对照组选择以充分控制偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Self-controlled designs, specifically the case-crossover (CCO) and the self-controlled case series (SCCS), are increasingly utilized to generate real-world evidence (RWE) on drug-drug interactions (DDIs). Although these designs share the advantages and limitations of within-individual comparison, they also have design-specific assumptions. It is not known to what extent the differences in assumptions lead to different results in RWE DDI analyses. Using a nationwide US commercial healthcare insurance database (2006-2016), we compared the CCO and SCCS designs, as they are implemented in DDI studies, within five DDI-outcome examples: (1) simvastatin + clarithromycin and muscle-related toxicity; (2) atorvastatin + valsartan, and muscle-related toxicity; and (3-5) dabigatran + P-glycoprotein inhibitor (clarithromycin, amiodarone, and verapamil) and bleeding. Analyses were conducted within person-time exposed to the object drug (statins and dabigatran) and adjusted for bias associated with the inhibiting drugs via control groups of individuals unexposed to the object drug. The designs yielded similar estimates in most examples, with SCCS displaying better statistical efficiency. With both designs, results varied across sensitivity analyses, particularly in CCO analyses with small number of exposed individuals. Analyses in controls revealed substantial bias that may be differential across DDI-exposed and control individuals. Thus, both designs showed no association between amiodarone or verapamil and bleeding in dabigatran-exposed but revealed strong positive associations in controls. Overall, bias adjustment via a control group had a larger impact on results than the choice of a design, highlighting the importance and challenges of appropriate control group selection for adequate bias control in self-controlled analyses of DDIs.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bykov K, Li H, Kim S, et al. Drug-Drug Interaction Surveillance Study: Comparing Self-Controlled Designs in Five Empirical Examples in Real-World Data. Clin Pharmacol Ther. 2020. PMID: 33245789. doi:10.1002/cpt.2119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。